PDK1 and cancer: PDK1 inhibitors have been proposed as potential cancer drugs (52, 53) and consistent with our findings, the PDK inhibitor AZ10219759 was reported to cause lipid accumulation in the heart with subsequent necrosis and atrial tissue degeneration (54).